rna editing

News

Wave Life Sciences president and CEO Paul Bolno

Wave surges on first RNA editing data in humans

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD).

R&D

Pioneering RNA Editing Drugs Towards Clinical Realities

Partner Content

5th RNA Editing Summit 2024

Pioneering RNA Editing Drugs Towards Clinical Realities

Events

RNA Editing Summit - PharmaPhorum Banner Final

Partner Content

2nd RNA Editing Summit 2020

Industry led meeting on RNA Editing mechanisms

Wave surges on first RNA editing data in humans

5th RNA Editing Summit 2024

2nd RNA Editing Summit 2020

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks